Celebrolysin 60mg Research Compound

Celebrolysin (Cerebrolysin) is not a single peptide — it’s a complex mixture of low‑molecular‑weight neuropeptides derived from porcine brain proteins, designed to mimic natural neurotrophic factors like BDNF, NGF, GDNF, and CNTF. It’s used clinically in parts of Europe and Asia for stroke recovery, dementia, traumatic brain injury, and experimentally as a high‑end nootropic

Research being Documented (Clinical + Experimental)

1. Neuroprotection

Protects neurons from ischemic damage and oxidative stress. Supported in TBI and neurodegenerative models.

2. Neuroplasticity & Synaptic Growth

Activates PI3K/Akt, MAPK, and CREB pathways → improved learning and memory.

3. Cognitive Enhancement

Most consistent improvements:

• Memory formation

• Processing speed

• Verbal fluency

• Executive function Effects often appear after 1–4 weeks of a treatment cycle.

4. Potential Clinical Uses

Evidence ranges from promising to inconclusive:

• Vascular dementia → modest improvement

• Alzheimer’s disease → preliminary benefit, needs better trials

• Traumatic brain injury → multiple meta‑analyses show functional improvement

• Stroke → recent Cochrane review: no clear benefit and possible increased adverse events

⚠️ Safety & Side Effects

Celebrolysin is generally well‑tolerated but can cause:

• Headache

• Dizziness

• Nausea

• Sweating

• Injection‑site irritation

Not recommended for:

• Epilepsy

• Severe kidney disease

• Hypersensitivity to porcine proteins

Research Disclaimer: BLVE products are for laboratory and scientific research only and are not intended for human consumption, veterinary use, clinical application, or therapeutic treatment. All research must be conducted by qualified professionals in appropriate laboratory environments.